Hipotiroidizm ve Hipertiroidizmde Kardiyovasküler ... - Yeni Tıp Dergisi

Yeni Tp Dergisi 2011;28: N. Barış ve 30-33 ark.REFERANSLAR1. Turhan S, Sezer S, Erden G, Guctekin A, Ucar F, Ginis Z, et al.Plasma homocysteine concentrations and serum lipid profile asatherosclerotic risk factors in subclinical hypothyroidism. Annals of SaudiMedicine 2008;28: 96-101.2. Diekman MJM, Vander Put NM, Blom HJ, Tijssen JGP, WiersingaWM. Determinants of changes in plasma homocysteine in hyperthyroidismand hypothyroidism. Clinical Endocrinology 2001;54: 197-204.3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitativeassessment of plasma homocysteine as a risk factor for vascular disease.Probable benefits of increasing folic acid intakes. The Journal Of AmericanMedical Association 1995;274: 1049-57.4. Miner SE, Evrovski J, Cole DE. Clinical chemistry and moleculerbiology of homocysteine metabolism: an update. Clinical Biochemistry1997;30: 189-201.5. Brattstrom L, Israelsson B, Tengborn L, Hultberg B. Homocysteine,factor VII, and antithrombin III in subjects with different gene dosage forcystathionine β-synthase. Journal of Inherited Metabolic Disease 1989;12:475-82.6. Duntas LH. Thyroid disease and lipids. Thyroid 2002;12: 267–93.7. Diekman T, Demacker PN, Kastelein JJ, Stalenhoef AF, WiersingaWM. Increased oxidizability of low-density lipoproteins in hypothyroidism.Journal of Clinical Endocrinology and Metabolism 1998;83: 1752–5.8. Sundaram V, Hanna AN, Koneru L, Newman H.A, Falko J.M. Bothhypothyroidism and hyperthyroidism enhance low density lipoproteinoxidation. Journal of Clinical Endocrinology and Metabolism 1997;82: 3421–4.9. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P.Low grade inflammation and coronary heart disease: prospective study andupdated meta-analyses. British Medical Journal 2000;321: 199–204.10. Ridker P.M. Clinical application of C-reactive protein forcardiovascular disease detection and prevention. Circulation 2003;107:363–9.11. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinicalhypothyroidism may be associated with elevated high-sensitive c-reactiveprotein (low grade inflammation) and fasting hyperinsulinemia. EndocrineJournal 2005;52: 89-94.12. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W,Staub JJ, et al. Elevated C-reactive protein and homocysteine values:cardiovascular risk factors in hypothyroidism? A cross-sectional and adouble-blind, placebo-controlled trial. Atherosclerosis 2003;166: 379–86.13. Pantos C, Mourouzis I, Xinaris C, Cokkinos DV. Thyroid hormoneand myocardial ischaemia. The Journal of Steroid Biochemistry andMolecular Biology 2008;109: 314-22.14. Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, et al.Thyroid hormones and the cardiovascular system: pathophysiology andinterventions. Biomedicine & Pharmacotherapy 2009;63: 742-53.15. Liu XQ, Rahman A, Bagdade JD, Alaupovic P, Kannan CR. Effect ofthyroid hormone on plasma apolipoproteins and apoA- and apoB-containinglipoprotein particles. European Journal of Clinical Investigation 1998;28:266-70.16. Salter AM, Hayashi R, al-Seeni M, Brown NF, Bruce J, Sorensen O,et al. Effects of hypothyroidism and high-fat feeding on mRNAconcentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver. Biochemical Journal1991:276: 825-32.17. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J,et al. DACH-LIGA homocystein (german, austrian and swiss homocysteinesociety): consensus paper on the rational clinical use of homocysteine, folicacid and B-vitamins in cardiovascular and thrombotic diseases: guidelinesand recommendations. Clinical Chemistry and Laboratory Medicine2003;41: 1392-403.18. Eikelboom JW, Hankey GJ. Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease.Current Opinion in Nephrology & Hypertension 2001;10(3):377-83.19. Young IS, Woodside JV. Folate and homocysteine. Current Opinionin Clinical Nutrition & Metabolic Care 2000;3: 427-32.20. Barbe F, Klein M, Chango A, Fremont S, Gerard P, Weryha G, et al.Homocysteine, folate, vitamin B12, and transcobalamins in patientsundergoing successive hypo-and euthyroid states. The Journal of ClinicalEndocrinology and Metabolism 2001;86: 1845-6.21. Cakal B, Cakal E, Demirbas B, Ozkaya M, Karaahmetoglu S, SerterR, et al. Homocysteine and Fibrinogen Changes with L-thyroxine inSubclinical Hypothyroid Patients. Journal of Korean Medical Science2007;22: 431-5.22. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH.Hyperhomocysteinemia and hypercholesterolemia associated withhypothyroidism in the third US National Health and Nutrition ExaminationSurvey. Atherosclerosis 2001;155: 195-200.23. Nair CP, Viswanathan G, Noronha JM. Folate-mediatedincorporation of ring-2-carbon of histidine into nucleic acids: influence ofthyroid hormone. Metabolism 1994;43: 1575-8.24. Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, etal. Adiponectin levels and cardiovascular risk factors in hypothyroidism andhyperthyroidism. Clinical Endocrinology 2006;65: 530-5.3233